BRD3 and ovarian serous carcinoma: mRNA expression of BRD3 exhibited no association with OS in all ovarian carcinoma as well as in serous ovarian carcinoma patients, HR= 0.91 (0.79 - 1.04), P= 0.15 (Figure 4A); HR= 0.9 (0.77 - 1.05), P= 0.17 (Figure 4B).